The Role of Opioid Peptides in Psychostimulant Addiction
A special issue of Brain Sciences (ISSN 2076-3425). This special issue belongs to the section "Developmental Neuroscience".
Deadline for manuscript submissions: closed (25 February 2020) | Viewed by 628
Special Issue Editor
Interests: neuropeptides; drug and natural reward; pain; addiction; psychostimulants and other addictive drugs
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Opioid peptides are found in the central nervous system (CNS) and peripheral nervous system (PNS) and have long been implicated in the modulation of pain, the regulation of the stress response, feeding, motivated behaviors, etc. Opioid peptides have also been known to regulate the activity of the mesolimbic dopaminergic neurons that are associated with the rewarding and reinforcing actions of addictive drugs, such as psychostimulants, alcohol, and nicotine. Accumulating evidence suggests that opioid peptides are also involved in the rewarding and reinforcing actions of amphetamine and cocaine. A comprehensive review of the role of each opioid peptide in the rewarding and reinforcing actions of amphetamine and cocaine is essential. This research topic focuses on the role of opioid peptides in the rewarding and reinforcing actions of psychostimulants as well as negative affective states, such as anxiety, depression, and anhedonia, which are associated with withdrawal from such reinforcers. This research topic is also expected to establish a link between opioid peptides and the development of psychostimulant addiction and other neuropsychiatric disorders associated with the continued use of these drugs as well as following their withdrawal.
Prof. Dr. Kabirullah Lutfy
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Brain Sciences is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Reward and/or reinforcement
- Withdrawal and/or reinstatement
- Psychostimulant addiction
- Cocaine
- Amphetamine and/or methamphetamine
